Company / FCF Margin
Valion Bio, Inc. FCF Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-733.8%
FY2024
5-year range
-733.8% / -447.3%
FY2022-FY2024
Trend
-51.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -447.3% to -733.8% over the past 2 years.
Based on SEC 10-K filings.
-733.8% in FY2024.
Declined from -447.3% to -733.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin decreased 51.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -733.8% | -51.2% |
| FY2023 | -485.3% | -8.5% |
| FY2022 | -447.3% | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026